SciSparc subsidiary NeuroThera reports successful CliniQuantum analysis
SciSparc said its subsidiary NeuroThera Labs reported successful quantum-enabled analysis using real-world clinical data on an S&P 500 company’s quantum architecture.
SciSparc said its subsidiary NeuroThera Labs reported successful quantum-enabled analysis using real-world clinical data on an S&P 500 company’s quantum architecture.